IDiyas

For the Inventor, By the Inventor

Ishioka, Japan

Shigehiro Takase

USPTO Granted Patents = 27

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • Nishinomiya, JP (1987 - 1989)
  • Ibaraki, JP (1989 - 1995)
  • Tsukuba, JP (1990 - 1995)
  • Ishioka, JP (1993 - 2004)

Company Filing History:

goldMedal27 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1987-2004

Loading Chart...
27 patents (USPTO):Explore Patents
1. 6730776 - WF14573 or its salt, production thereof and use thereof (2004-05-04),
2. 6656905 - Cyclic tetrapeptide compound and use thereof (2003-12-02),
3. 6521600 - Compound, WF002, production thereof and use thereof (2003-02-18),
4. 6399567 - Cyclic hexapeptides having antibiotic activity (2002-06-04),
5. 6331521 - Echinocandine derivatives with antimicrobial activity (2001-12-18),
6. 6110933 - Amino acid derivatives and their use as phospholipase A.sub.2 inhibitor (2000-08-29),
7. 5547934 - WF11243 substance (1996-08-20),
8. 5545542 - WB2663 substances and method for their production (1996-08-13),
9. 5447854 - Production of cyclosporin A and/or C with a strain of NECTRIA (1995-09-05),
10. 5446022 - WF11243 substance (1995-08-29),
11. 5436140 - Process for producing WS-9326A and WS-9326B (1995-07-25),
12. 5409701 - FR901451 substance, process for preparation thereof and use thereof (1995-04-25),
13. 5364624 - WS7622A mono- or di-sulfate, process for preparation thereof and use (1994-11-15),
14. 5292510 - WS7622A mono- or di- sulfate, process for preparation thereof and use (1994-03-08),
15. 5279826 - Prophylactic/therapeutic composition for disseminated intravascular (1994-01-18),

Title: Shigehiro Takase: Innovator in Antimicrobial Compounds

Introduction

Shigehiro Takase is a prominent inventor based in Ishioka, Japan, known for his significant contributions to the field of antimicrobial compounds. With a portfolio of 27 patents, his work has made a considerable impact in pharmaceutical innovations.

Latest Patents

One of Takase's latest inventions is described in patent WF14573. This patent presents a new antimicrobial compound, WF14573, and outlines a method for producing it through culturing specific microorganisms or by deacylating existing compounds. The patent also covers various applications of WF14573, including its use in antimicrobial agents and pharmaceutical compositions aimed at treating infectious diseases caused by pathogenic microorganisms. Additionally, he has developed a cyclic tetrapeptide compound, WF27082, which is produced by culturing a specific strain of Acremonium. This compound has potential applications in treating various serious health conditions, such as inflammatory disorders and tumors.

Career Highlights

Takase is affiliated with Fujisawa Pharmaceutical Company, Ltd., where he has made significant strides in pharmaceutical research and development. His innovative approaches and dedication to improving antimicrobial solutions have positioned him as a leader in his field.

Collaborations

Throughout his career, Takase has collaborated with notable professionals such as Masakuni Okuhara and Masanori Okamoto. These partnerships have fostered an environment of innovation, contributing to the successful development and application of his patented inventions.

Conclusion

Shigehiro Takase continues to be an influential figure in the realm of antimicrobial compounds, with a strong commitment to enhancing pharmaceutical options. His innovative patents and collaborative spirit exemplify the role of inventors in advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…